Click Here to return To Results

 

Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial Lancet 387:1921-1927,1882, Villiger, P.M.,et al, 2016 See this aricle in Pubmed Article Abstract Our findings show, for the first time in a trial setting, the efficacy of tocilizumab in the induction and maintenance of remission in patients with giant cell arteritis.

Related Tags

(click to filter results - removes previous filter) arteritis,temporal arteritis,temporal,recurrent efficacy giant cell arteritis interleukin 6 monoclonal antibodies tocilizumab treatment of neurologic disorder

Click Here to return To Results